Every year, millions of older adults take more medications than they need. Some have been on the same pills for decades - a daily statin, a nighttime sleep aid, a stomach acid reducer - not because they still help, but because no one ever asked if they still mattered. This isn’t laziness. It’s inertia. And it’s dangerous.

Deprescribing isn’t about stopping meds because they’re expensive or inconvenient. It’s about stopping them because they’re doing more harm than good. The goal? Reduce side effects, lower the risk of falls, avoid hospital trips, and give people back their quality of life. And there’s a clear, step-by-step way to do it - called a deprescribing framework.

What Exactly Is Deprescribing?

Deprescribing means carefully and systematically cutting back or stopping medications that may no longer be helping - or are now causing more problems than they solve. It’s not just "going off drugs." It’s a clinical process, like prescribing, but in reverse. You don’t just pull the plug. You plan it. You monitor it. You listen to the patient.

It’s especially important for people over 65. According to the World Health Organization, about 40% of older adults worldwide take five or more medications at once - a situation called polypharmacy. That number jumps even higher in nursing homes or after hospital stays. And guess what? One in three hospital admissions for people over 65 is linked to medication side effects. That’s not a coincidence. It’s a system failure.

Deprescribing frameworks fix that. They give doctors, pharmacists, and nurses a roadmap. Not guesswork. Not opinion. Evidence-based steps.

The Five Key Medication Classes That Need Deprescribing

Not all drugs are equal when it comes to risk. Some are more likely to cause harm than others - especially in older bodies. The most common culprits? Five classes with clear, validated deprescribing guidelines:

• Proton-pump inhibitors (PPIs) - These are stomach acid blockers like omeprazole. Many take them for heartburn, but most don’t need them long-term. After 4-8 weeks, the body adjusts. Staying on them increases risk of bone fractures, kidney damage, and gut infections.
• Benzodiazepines and sleep aids - Drugs like lorazepam or zolpidem. They help with anxiety or insomnia short-term. Long-term? They increase fall risk by 50%, worsen memory, and can cause dependence. Tapering them slowly cuts these risks without triggering seizures or rebound insomnia.
• Antipsychotics - Prescribed for dementia-related agitation? That’s off-label. And dangerous. These drugs raise stroke risk by 2-3 times in older adults with dementia. Deprescribing here can mean fewer hospitalizations and better behavior without drugs.
• Antihyperglycemics - Blood sugar drugs like sulfonylureas. Tight control in older adults with limited life expectancy doesn’t extend life - it just causes dangerous lows. Deprescribing can prevent hypoglycemic episodes that lead to falls, confusion, or ER visits.
• Opioid analgesics - Painkillers like oxycodone. Long-term use for chronic pain rarely improves function. But it does increase drowsiness, constipation, and overdose risk. Deprescribing here means switching to non-drug options like physical therapy or mindfulness.

Each of these has a published guideline. For example, the PPI deprescribing protocol is four steps: 1) Check if the original reason still exists, 2) Evaluate if the benefit outweighs the risk, 3) Taper slowly over 4-8 weeks, 4) Watch for return of symptoms. No rush. No guesswork.

The Shed-MEDS Framework: A Proven Method

One of the most tested deprescribing frameworks is called Shed-MEDS. It stands for:

1. Search - Get the full list of every medication the patient takes, including supplements and OTC pills.
2. Hold - Pause all non-essential meds temporarily. Don’t stop yet. Just pause.
3. Evaluate - Review each one. Is it still needed? Is it safe? Is it helping?
4. Deprescribe - Decide what to stop, in what order, and how fast.
5. Synthesize - Document the plan. Share it. Monitor.

A 2023 study in JAMA Internal Medicine followed 372 older adults in post-acute care. Those using Shed-MEDS had their medication count drop from 11.3 to 9.5 on average. At 90 days, it was still down by 1.6 drugs. And here’s the kicker: no increase in falls, hospitalizations, or deaths. The group that didn’t deprescribe? Same safety outcomes - but with 2 more pills daily.

Who Does It Best? Pharmacists.

Deprescribing doesn’t work well in a 7-minute doctor visit. It needs time. It needs expertise. And it needs someone who knows every drug interaction, every withdrawal symptom, every alternative.

That’s where pharmacists come in. Studies show that when pharmacists lead deprescribing efforts, success rates jump by 35-40%. Why? Because they’re trained in medication therapy management - a 150+ hour certification that teaches them how to untangle complex regimens.

In Canada, where the Deprescribing Guidelines in the Elderly (DIGE) program is nationally adopted, pharmacists review all prescriptions for seniors on public drug plans. Result? A 25% drop in inappropriate prescribing in just three years.

But in the U.S., only 32% of clinicians feel their electronic health record (EHR) system supports deprescribing. Most EHRs are built to encourage prescribing - not stopping. A pill gets added with one click. Stopping one? You have to hunt through menus, write notes, justify it. No wonder it doesn’t happen.

Why Don’t More Doctors Do It?

It’s not that they don’t want to. It’s that they’re stuck.

A primary care physician in the U.S. spends an average of 7.2 minutes per patient visit. That’s not enough to review 10 medications, discuss goals of care, check for drug interactions, explain why stopping a pill won’t kill them, and get consent.

Plus, guidelines are fragmented. Out of 3,569 evidence-based recommendations in clinical guidelines, only 7% mention deprescribing. Compare that to prescribing - 93% of guidelines tell you what to start. Almost none tell you what to stop.

And fear plays a role. Patients are scared. "I’ve taken this for 20 years - what if I get sick?" Doctors are scared too. "What if I stop this and they end up in the ER?"

But the data says otherwise. In the same 2023 study, only 15.8% of patients who deprescribed had adverse events - compared to 16.2% in the control group. No difference. That’s not luck. That’s science.

What Patients Really Think

When patients are involved, they usually agree - if they understand why.

A 2022 study found 65% of older adults felt relieved when they stopped unnecessary pills. "I don’t have to swallow 15 tablets every morning," one said. "I feel lighter."

But 22% were anxious. One woman cried when her doctor suggested stopping her long-term blood pressure pill. "My husband died because he stopped his meds too soon," she said. She didn’t know he had heart failure - and his meds were lifesaving. Her fear was real.

That’s why education matters. Not just about the drug - but about the goal. "We’re not trying to make you healthier by adding more pills. We’re trying to make you feel better by removing the ones that aren’t helping."

The Future Is Here - But Slowly

Change is coming. In June 2024, the American Medical Association passed its first policy requiring physicians to routinely review all medications. In February 2024, Medicare announced it will start measuring deprescribing rates in 2026 - and tie payments to performance.

AI tools are being built to flag high-risk combinations in EHRs. New guidelines are in development for antidepressants, anticoagulants, and other classes. The global deprescribing market is projected to hit $1.2 billion by 2028.

But real progress won’t come from technology alone. It comes from doctors who have time. Pharmacists who are part of the team. Patients who are heard.

By 2030, experts predict deprescribing assessments will be as routine as checking blood pressure. And that’s a good thing. Because sometimes, the best medicine is the one you don’t take anymore.